Your browser doesn't support javascript.
loading
Ring-ing in the Future: Participant and Male Partner Perspectives Regarding Future Use of the Dapivirine Vaginal Ring for HIV Prevention.
Reddy, Krishnaveni; Mathebula, Florence; Katz, Ariana; Luecke, Ellen; Tenza, Siyanda; Palanee-Phillips, Thesla; Garcia, Morgan; Mansoor, Leila E; Naidoo, Sarita; Morar, Neetha; Chitukuta, Miria; Tsidya, Mercy; Montgomery, Elizabeth T.
Afiliación
  • Reddy K; Wits Reproductive Health and HIV Institute (Wits RHI), University of the Witwatersrand, 7 Esselen Street, Hillbrow, Johannesburg, 2038, South Africa. kreddy@wrhi.ac.za.
  • Mathebula F; Wits Reproductive Health and HIV Institute (Wits RHI), University of the Witwatersrand, 7 Esselen Street, Hillbrow, Johannesburg, 2038, South Africa.
  • Katz A; Women's Global Health Imperative (WGHI), RTI International, Berkeley, CA, USA.
  • Luecke E; Women's Global Health Imperative (WGHI), RTI International, Berkeley, CA, USA.
  • Tenza S; Wits Reproductive Health and HIV Institute (Wits RHI), University of the Witwatersrand, 7 Esselen Street, Hillbrow, Johannesburg, 2038, South Africa.
  • Palanee-Phillips T; Wits Reproductive Health and HIV Institute (Wits RHI), University of the Witwatersrand, 7 Esselen Street, Hillbrow, Johannesburg, 2038, South Africa.
  • Garcia M; FHI 360, Durham, NC, USA.
  • Mansoor LE; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
  • Naidoo S; South African Medical Research Council, HIV Prevention Research Unit, KwaZulu-Natal, South Africa.
  • Morar N; The Aurum Institute, Johannesburg, South Africa.
  • Chitukuta M; South African Medical Research Council, HIV Prevention Research Unit, KwaZulu-Natal, South Africa.
  • Tsidya M; University of Zimbabwe College of Health Sciences Clinical Trials Research Centre (UZCHS-CTRC), Harare, Zimbabwe.
  • Montgomery ET; University of North Carolina (UNC) Project, Lilongwe, Malawi.
AIDS Behav ; 26(6): 1923-1932, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35064389
ABSTRACT
Women account for a disproportionate percentage of new HIV infections in sub-Saharan Africa indicating a need for female-initiated HIV prevention options congruent with their lifestyles. The dapivirine vaginal ring for HIV prevention is one such option. We explored the interest of women, who used this ring during the Microbicide Trials Network's ASPIRE and HOPE studies, in using the ring post-licensure and what they perceived as important considerations for future use. We also explored perspectives of HOPE participants' male partners on their involvement in their partners' future ring use. Women appeared keen to use the ring in the future and expressed desires for easy access, support for both ongoing and new users and intense community engagement. In parallel, male partners indicated high levels of interest in supporting their partners' ring use and being involved in ring use decision making. These data offer important insights for ring rollout planning and engagement activities.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Dispositivos Anticonceptivos Femeninos / Fármacos Anti-VIH Límite: Female / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Dispositivos Anticonceptivos Femeninos / Fármacos Anti-VIH Límite: Female / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article